title: Modulation of tau neuronal expression induced by NMDA, non-NMDA and metabotropic glutamate receptor agonists.
abstract: We have analysed changes in tau protein immunoreactivity in rat embryonic neurons degenerating in response to treatment with N-methyl-D-aspartate (NMDA), non-NMDA and metabotropic agonists. Glutamate agonists were applied in Mg(++)-free and glycine-supplemented medium 8 days after initial plating. Cell viability was assessed by fluorescein diacetate staining and neuronal survival was evaluated by cell counting. Immunocytochemical and confocal laser microscopic studies used a tau2 monoclonal antibody. Acute and chronic NMDA treatment induced a concentration-dependent increase in intraneuronal tau immunoreactivity. Increased tau immunolabelling during chronic NMDA toxicity was dramatically attenuated by tetrodotoxin and also by 6-cyano-7-nitroquinoxaline-2,3-dione. Non-NMDA and metabotropic receptor agonist treatment produced a weaker augmentation in tau2 immunoreactivity. These findings suggest that, in this model, glutamate-receptor and sodium-channel coactivation are together needed to produce changes in tau immunoreactivity.
authors.affiliation: Unité de Neurobiologie Cellulaire, Faculté de Médecine, Limoges, France.
authors.forename: P
authors.initials: P
authors.lastname: Couratier
authors.forename: P
authors.initials: P
authors.lastname: Sindou
authors.forename: F
authors.initials: F
authors.lastname: Tabaraud
authors.forename: A G
authors.initials: AG
authors.lastname: Diop
authors.forename: P S
authors.initials: PS
authors.lastname: Spencer
authors.forename: J
authors.initials: J
authors.lastname: Hugon
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D016291:Dizocilpine Maleate / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D018613:Microscopy, Confocal; D009474:Neurons / Q000737:chemistry*; D051381:Rats; D017208:Rats, Wistar; D018091:Receptors, AMPA / Q000819:agonists*; D018094:Receptors, Metabotropic Glutamate / Q000819:agonists*; D016194:Receptors, N-Methyl-D-Aspartate / Q000819:agonists*; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / Q000494:pharmacology; D016875:tau Proteins / Q000032:analysis*
chemical_list: D018091:Receptors, AMPA; D018094:Receptors, Metabotropic Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D016875:tau Proteins; D000001:Calcimycin; D016291:Dizocilpine Maleate; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid